Upcoming Allied Market Research
Growth Hormone Deficiency Market

Growth Hormone Deficiency Market

by Brand (Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Others), by Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age, Other) and by End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A12326
Pages: NA
Jul 2023 | 1301 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Growth Hormone Deficiency Market

Request Now !

Human growth hormone (hGH) or somatotropin is a peptide hormone responsible for cell reproduction, growth stimulation, and cell regeneration in humans. In human growth hormone (GH) deficiency is caused when the pituitary gland is unable to synthesize enough concentration of hGH. This deficiency is treated by subcutaneously administering recombinant hGH. Various genetic disorders, including Turner syndrome and Prader–Willi syndrome, may cause growth hormone deficiency in humans, leading to shorter-than-average height and delayed puberty.

According to data published by the American Academy of Pediatrics, in the U.S., growth hormone deficiency affects less than one in 3,000 to one in 10,000 children. hGH is currently being abused by bodybuilders and athletes as an anti-aging treatment and as a performance-enhancing anabolic drug. However, according to the USFDA, hGH is a controlled substance that has not been authorized for anti-aging or performance-enhancing purposes.

COVID-19 Impact analysis

Following the COVID-19 outbreak, the emphasis has shifted toward the enhanced production of effective and affordable drugs, with the pandemic shining a light on healthcare inequities. For the accelerated drug development rate, the demand for real-world evidence has increased considerably, with major companies now opting for remote monitoring as well as source document verification (SDV), ensuring that patients can benefit despite the COVID-19 pandemic. While COVID-19 gets healthcare’s attention, growth hormone deficiency continues to be the focus areas in many countries. Therefore, studies are in progress to know the importance of growth hormone drugs and foster their application scope. In the post-pandemic era, the demand for the pediatric growth hormone market has also been favorable.

Top Impacting Factors

  • The market growth is attributed to increase in growth hormone deficiency disorders and rise in growth hormone usage to control aging.
  • In addition, rise in awareness of the treatment procedure and increase in neuropsychiatric cases propel the human growth hormone market.
  • The introduction of novel therapies as well as robust pipeline and surge in R&D investments augment the market growth.
  • However, high cost of the treatment and fluctuations in drug productivity in pharmaceutical companies restraint the market growth.
  • Side effects such as fluid retention, joint pain, and muscle pain related to synthetic growth hormones are the key deterrent factors for market growth.
  • The surge in FDA approvals is also providing opportunities to the key players to develop novel drugs that have fewer side effects.

Market Trends

New product launches to flourish the market

In September 2018, Novo Nordisk presented Phase II clinical trial data of its investigational GH therapy, Somapacitan, indicated for the treatment of pediatric growth hormone deficiency.

In May 2019, Ascendis Pharma A/S published results from the Phase III clinical trial of its TransCon hGH, indicated for pediatric growth hormone deficiency.

In November 2020, GenScience Pharmaceuticals entered an exclusive agreement with Foresee Pharmaceuticals for commercializing the latter’s FP-001 program, Leuprolide Mesylate Injectable Suspension—subcutaneous, ready-to-use 3-month and 6-month depot formulations or Camcevi. This agreement will be solely focusing on the Chinese market.

November 2020, Aeterna teamed up with Novo Nordisk with the aim to boost the application scope of macimorelin that helps diagnose growth hormone deficiency, which is childhood onset. The company believes that this area is considerably untapped, and therefore needs to explore the unmet needs. Aeterna is currently in the early stage of clinical safety as well as efficacy study, which focuses on analyzing Macimorelin for detection of CGHD.

Surge in GH Deficiency Cases to be a Key Growth Booster

Growth hormone deficiency has become a huge problem for the healthcare industry, and the most common reason for the same is considered to be a brain injury. This condition is marked with a host of symptoms, such as reduced energy levels, lower muscle strength, altered body composition, osteoporosis, insulin resistance, and lipid abnormalities that include high LDL cholesterol. Therefore, the growth hormone market share is expected to be bolstered by the rising GH deficiency disorders worldwide.

Key Benefits of the Report

  • This study presents the analytical depiction of the growth hormone deficiency along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Growth Hormone Deficiency Report

  • Which are the leading players active in the growth hormone deficiency market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "growth hormone deficiency "?
  • What is "growth hormone deficiency” market prediction in the future?
  • Who are the leading global players in the "growth hormone deficiency” market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "growth hormone deficiency” market report?

Growth Hormone Deficiency Market Report Highlights

Aspects Details
By Brand
  • Norditropin
  • Genotropin
  • Humatrope
  • Saizen
  • Omnitrope
  • Others
By Application
  • Growth Hormone Deficiency
    • Adult GH Deficiency
    • Pediatric GH Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature
  • Prader-Willi Syndrome
  • Small for Gestational Age
  • Other
By End User
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Specialty Pharmacy
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Teva Pharmaceutical Industries, Ltd, Novartis AG, Merck KGaA, Novo Nordisk A/S, Ferring B.V., Roche, Ipsen, Eli Lilly and Company, Pfizer, Inc, Ferring Pharmaceuticals

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.


Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Growth Hormone Deficiency Market

Start reading.
This Report and over 53,854+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers